Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  01:00 2022-11-25 pm EST
551.25 USD   +0.72%
11/21Thermo Fisher Scientific Issues 1.25 Billion Euros of 2026, 2034 Notes
MT
11/21Thermo Fisher Scientific Inc. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/21Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Launches A More Sustainable Solution for Large-Scale Cell Culture Harvesting

09/28/2022 | 08:00am EST

Thermo Fisher Scientific Inc., unveiled the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system at the BioProcess International annual conference in Boston, MA. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. The DynaSpin system improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

The DynaSpin solution delivers equivalent or improved product yield compared to traditional harvest systems while enabling operational efficiency, cost savings and sustainable practices in the production of biologics. The DynaSpin system helps reduce overall production costs while allowing biologic manufacturers to support their sustainability goals. By reducing the number of filters required for harvesting, this product offers upwards of six-fold reduction in material requirements, eliminating 70% of waste compared to traditional harvest systems. In addition to the optimized design and smaller equipment footprint, the DynaSpin system incorporates the well-documented advantages of single-use products including scalability, rapid change over, reduced downtime and lower risk of contamination to the workflow.

The ergonomic design of the system provides ease of access for system operation and maintenance, including loading and unloading the single-use rotor and line set assembly. DynaSpin brings automation technology not previously available in single-use solutions for harvesting. It provides configurable user access, audit trail and batch reporting, allowing the users to meet 21 CFR Part 11 compliance.


ę S&P Capital IQ 2022
All news about THERMO FISHER SCIENTIFIC
11/21Thermo Fisher Scientific Issues 1.25 Billion Euros of 2026, 2034 Notes
MT
11/21Thermo Fisher Scientific Inc. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
11/21Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
BU
11/18Insider Sell: Thermo Fisher Scientific
MT
11/16Thermo Fisher Scientific : Introduces Rapid Point-of-Care RT-PCR Flu A/Flu B Test
PU
11/16Thermo Fisher Scientific to Seek Acquisitions
CI
11/16Thermo Fisher Scientific Introduces All-In-One AAV Production System for Scalable Gene ..
CI
11/15Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
BU
11/15Thermo Fisher Scientific Prices Offering of €1.25 Billion Aggregate Principal Amou..
CI
11/15Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
BU
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 43 842 M - -
Net income 2022 6 919 M - -
Net Debt 2022 24 995 M - -
P/E ratio 2022 31,5x
Yield 2022 0,21%
Capitalization 217 B 217 B -
EV / Sales 2022 5,52x
EV / Sales 2023 5,42x
Nbr of Employees 130 000
Free-Float 88,9%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 551,25 $
Average target price 615,94 $
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors